Strong Evidence Base HelloBetter's extensive portfolio of 33 peer-reviewed randomized controlled trials and integration into standard care in Germany demonstrates its credibility and effectiveness, making it an attractive partner for healthcare providers and insurance companies seeking evidence-based digital mental health solutions.

International Expansion The recent launch of HelloGina in the US and the company's expansion efforts indicate a growing market presence, presenting opportunities for partnerships with international health organizations, employers, and clinics seeking innovative sexual wellness and mental health solutions.

Funding & Growth With over €31 million in funding from notable investors like Mutuelles Impact and HSBC Asset Management, HelloBetter is positioned for scaling its digital therapeutics platform and entering new markets, offering potential for strategic collaborations and product integrations.

Innovative Products The development of targeted programs such as HelloBetter Panic and the launch of Mein MentalHealthCoach showcase the company's focus on specialized, evidence-based interventions, creating opportunities to address diverse mental health needs within enterprise and health system channels.

Regulatory Recognition Receiving the FDA Breakthrough Device Designation for HelloBetter Panic signifies strong validation of its technology, positioning the company as a leader in digital therapeutics and opening doors for collaborations with healthcare institutions and governmental agencies.